MX2021012375A - Metodo para tratar y prevenir infecciones oseas y de articulaciones. - Google Patents

Metodo para tratar y prevenir infecciones oseas y de articulaciones.

Info

Publication number
MX2021012375A
MX2021012375A MX2021012375A MX2021012375A MX2021012375A MX 2021012375 A MX2021012375 A MX 2021012375A MX 2021012375 A MX2021012375 A MX 2021012375A MX 2021012375 A MX2021012375 A MX 2021012375A MX 2021012375 A MX2021012375 A MX 2021012375A
Authority
MX
Mexico
Prior art keywords
gram
treating
bone
preventing
seq
Prior art date
Application number
MX2021012375A
Other languages
English (en)
Spanish (es)
Inventor
Raymond Schuch
Original Assignee
Contrafect Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Contrafect Corp filed Critical Contrafect Corp
Publication of MX2021012375A publication Critical patent/MX2021012375A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Surgery (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Dispersion Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Dermatology (AREA)
  • Otolaryngology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
MX2021012375A 2019-04-11 2020-04-10 Metodo para tratar y prevenir infecciones oseas y de articulaciones. MX2021012375A (es)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201962832754P 2019-04-11 2019-04-11
US201962849672P 2019-05-17 2019-05-17
US201962938812P 2019-11-21 2019-11-21
US202062964755P 2020-01-23 2020-01-23
PCT/US2020/027752 WO2020210691A1 (en) 2019-04-11 2020-04-10 Method of treating and preventing bone and joint infections

Publications (1)

Publication Number Publication Date
MX2021012375A true MX2021012375A (es) 2021-11-17

Family

ID=72752118

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2021012375A MX2021012375A (es) 2019-04-11 2020-04-10 Metodo para tratar y prevenir infecciones oseas y de articulaciones.

Country Status (11)

Country Link
US (1) US20220193186A1 (cg-RX-API-DMAC7.html)
EP (1) EP3980049A4 (cg-RX-API-DMAC7.html)
JP (1) JP2022526624A (cg-RX-API-DMAC7.html)
KR (1) KR20210151188A (cg-RX-API-DMAC7.html)
CN (1) CN114025783A (cg-RX-API-DMAC7.html)
AU (1) AU2020271116A1 (cg-RX-API-DMAC7.html)
BR (1) BR112021019884A2 (cg-RX-API-DMAC7.html)
CA (1) CA3136461A1 (cg-RX-API-DMAC7.html)
IL (1) IL286994A (cg-RX-API-DMAC7.html)
MX (1) MX2021012375A (cg-RX-API-DMAC7.html)
WO (1) WO2020210691A1 (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023081691A1 (en) * 2021-11-04 2023-05-11 Contrafect Corporation Method of treating and preventing bone and joint infections

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX383544B (es) * 2011-04-21 2025-03-14 Univ Rockefeller Lisinas de bacteriofago de streptococcus para la deteccion y tratamiento de bacterias gram positivas
AU2013259512B2 (en) * 2012-05-09 2018-01-25 Contrafect Corporation Bacteriophage lysin and antibiotic combinations against gram positive bacteria
RU2646102C2 (ru) * 2012-05-09 2018-03-01 Контрафект Корпорейшн Предотвращение, разрушение и обработка биопленки лизином бактериофага
CN109152822B (zh) * 2016-05-12 2023-12-05 抗非特公司 用于评估和确定抗菌多肽的最小抑制浓度的肉汤微量稀释法
CN112118861A (zh) * 2018-02-26 2020-12-22 康特拉费克特公司 修饰的PlySs2溶素及其用途
MX2020013935A (es) * 2018-06-22 2021-03-09 Contrafect Corp Lisinas y sus derivados que resensibilizan staphylococcus aureus y bacterias gram positivas a antibioticos.

Also Published As

Publication number Publication date
WO2020210691A1 (en) 2020-10-15
AU2020271116A1 (en) 2021-11-11
IL286994A (en) 2021-12-01
US20220193186A1 (en) 2022-06-23
EP3980049A1 (en) 2022-04-13
KR20210151188A (ko) 2021-12-13
CN114025783A (zh) 2022-02-08
EP3980049A4 (en) 2023-07-19
CA3136461A1 (en) 2020-10-15
JP2022526624A (ja) 2022-05-25
BR112021019884A2 (pt) 2022-01-18

Similar Documents

Publication Publication Date Title
RU2014149348A (ru) Предотвращение, разрушение и обработка биопленки лизином бактериофага
RU2018107249A (ru) Применение лизина для восстановления/увеличения антибактериальной активности антибиотиков в присутствии легочного сурфактанта, который ингибирует указанные антибиотики
PH12020550107A1 (en) Chromane monobactam compounds for the treatment of bacterial infections
RU2014149351A (ru) Комбинации лизина бактериофага и антибиотика против грам-положительных бактерий
WO2009111064A3 (en) Minocycline compounds and methods of use thereof
WO2009140215A3 (en) Method for treating drug-resistant bacterial and other infections with clioquinol, phanquinone, and related compounds
MX2021003084A (es) Compuestos antibacterianos.
CA2747703C (en) Compositions and methods for the treatment or the prevention of infections by e. coli
RU2011130278A (ru) Новые противобактериальные средства для лечения грамположительных инфекций
MX2021001564A (es) Diazabiciclooctanonas como inhibidores de serina beta-lactamasas.
WO2018155813A3 (ko) 엔테로코쿠스 패슘에 대하여 용균력을 가지는 신규한 항균단백질 efal-2
JP2013539776A5 (cg-RX-API-DMAC7.html)
WO2020102901A8 (en) Synthetic antibacterial compounds and uses thereof
JP2017533177A5 (cg-RX-API-DMAC7.html)
PH12021553086A1 (en) Medicament and use thereof for treating bacterial infections involving biofilm
PH12021552875A1 (en) METHODS AND COMPOSITIONS COMPRISING STAPHYLOCOCCUS PROTEIN A (SpA) VARIANTS
HRP20200195T1 (hr) Antibiotske terapije na bazi peptida porijeklom od vodenog bivola
WO2010041970A3 (en) Antibacterial phage peptides and methods of use thereof
CA3010564A1 (en) An antibacterial composition and a method of treating staphylococcal infections with the antibacterial composition
MX2023011616A (es) Compuestos de lactivicina, su preparacion y uso como agentes antibacterianos.
AU2012335397A8 (en) Novel bacteriophages
BR112021019884A2 (pt) Método de tratamento e prevenção de infecções ósseas e articulares
WO2019222502A8 (en) Endolysins active against bacillus bacteria, pharmaceutical compositions, and methods relating thereto
EP4487917A3 (en) Stabilizing therapeutic proteins with piperazin- or morpholine-containing zwitterionic buffering substances
WO2009124086A3 (en) Antibacterial drug for treatment of staphylococcus aureus and other gram-positive bacterial infections